134 related articles for article (PubMed ID: 23320616)
1. A reporter-based screen to identify potent 3' trans-splicing molecules for endogenous RNA repair.
Murauer EM; Koller U; Hainzl S; Wally V; Bauer JW
Hum Gene Ther Methods; 2013 Feb; 24(1):19-27. PubMed ID: 23320616
[TBL] [Abstract][Full Text] [Related]
2. Designing Efficient Double RNA trans-Splicing Molecules for Targeted RNA Repair.
Hüttner C; Murauer EM; Hainzl S; Kocher T; Neumayer A; Reichelt J; Bauer JW; Koller U
Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27669223
[TBL] [Abstract][Full Text] [Related]
3. Trans-splicing improvement by the combined application of antisense strategies.
Koller U; Hainzl S; Kocher T; Hüttner C; Klausegger A; Gruber C; Mayr E; Wally V; Bauer JW; Murauer EM
Int J Mol Sci; 2015 Jan; 16(1):1179-91. PubMed ID: 25569093
[TBL] [Abstract][Full Text] [Related]
4.
Liemberger B; Bischof J; Ablinger M; Hainzl S; Murauer EM; Lackner N; Ebner P; Kocher T; Nyström A; Wally V; Mayr E; Guttmann-Gruber C; Hofbauer JP; Bauer JW; Koller U
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901775
[TBL] [Abstract][Full Text] [Related]
5. Targeted Exon Skipping Restores Type VII Collagen Expression and Anchoring Fibril Formation in an In Vivo RDEB Model.
Turczynski S; Titeux M; Tonasso L; Décha A; Ishida-Yamamoto A; Hovnanian A
J Invest Dermatol; 2016 Dec; 136(12):2387-2395. PubMed ID: 27498345
[TBL] [Abstract][Full Text] [Related]
6. An RNA-targeted therapy for dystrophic epidermolysis bullosa.
Peking P; Koller U; Duarte B; Murillas R; Wolf S; Maetzig T; Rothe M; Kocher T; García M; Brachtl G; Schambach A; Larcher F; Reichelt J; Bauer JW; Murauer EM
Nucleic Acids Res; 2017 Sep; 45(17):10259-10269. PubMed ID: 28973459
[TBL] [Abstract][Full Text] [Related]
7. Construction and validation of an RNA trans-splicing molecule suitable to repair a large number of COL7A1 mutations.
Tockner B; Kocher T; Hainzl S; Reichelt J; Bauer JW; Koller U; Murauer EM
Gene Ther; 2016 Nov; 23(11):775-784. PubMed ID: 27434145
[TBL] [Abstract][Full Text] [Related]
8. Functional correction of type VII collagen expression in dystrophic epidermolysis bullosa.
Murauer EM; Gache Y; Gratz IK; Klausegger A; Muss W; Gruber C; Meneguzzi G; Hintner H; Bauer JW
J Invest Dermatol; 2011 Jan; 131(1):74-83. PubMed ID: 20720561
[TBL] [Abstract][Full Text] [Related]
9. Compound heterozygosity for a recessive glycine substitution and a splice site mutation in the COL7A1 gene causes an unusually mild form of localized recessive dystrophic epidermolysis bullosa.
Terracina M; Posteraro P; Schubert M; Sonego G; Atzori F; Zambruno G; Bruckner-Tuderman L; Castiglia D
J Invest Dermatol; 1998 Nov; 111(5):744-50. PubMed ID: 9804332
[TBL] [Abstract][Full Text] [Related]
10. 5'RNA
Mayr E; Ablinger M; Lettner T; Murauer EM; Guttmann-Gruber C; Piñón Hofbauer J; Hainzl S; Kaiser M; Klausegger A; Bauer JW; Koller U; Wally V
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163654
[TBL] [Abstract][Full Text] [Related]
11. K14 mRNA reprogramming for dominant epidermolysis bullosa simplex.
Wally V; Brunner M; Lettner T; Wagner M; Koller U; Trost A; Murauer EM; Hainzl S; Hintner H; Bauer JW
Hum Mol Genet; 2010 Dec; 19(23):4715-25. PubMed ID: 20861136
[TBL] [Abstract][Full Text] [Related]
12. Meganuclease-Mediated COL7A1 Gene Correction for Recessive Dystrophic Epidermolysis Bullosa.
Izmiryan A; Danos O; Hovnanian A
J Invest Dermatol; 2016 Apr; 136(4):872-875. PubMed ID: 26897595
[No Abstract] [Full Text] [Related]
13. Recessive dystrophic epidermolysis bullosa caused by COL7A1 hemizygosity and a missense mutation with complex effects on splicing.
Titeux M; Mejía JE; Mejlumian L; Bourthoumieu S; Mirval S; Tonasso L; Heller M; Prost-Squarcioni C; Hovnanian A
Hum Mutat; 2006 Mar; 27(3):291-2. PubMed ID: 16470588
[TBL] [Abstract][Full Text] [Related]
14. Mutation analysis and characterization of COL7A1 mutations in dystrophic epidermolysis bullosa.
Dang N; Murrell DF
Exp Dermatol; 2008 Jul; 17(7):553-68. PubMed ID: 18558993
[TBL] [Abstract][Full Text] [Related]
15. A novel screening system improves genetic correction by internal exon replacement.
Koller U; Wally V; Mitchell LG; Klausegger A; Murauer EM; Mayr E; Gruber C; Hainzl S; Hintner H; Bauer JW
Nucleic Acids Res; 2011 Sep; 39(16):e108. PubMed ID: 21685452
[TBL] [Abstract][Full Text] [Related]
16. Fibroblasts show more potential as target cells than keratinocytes in COL7A1 gene therapy of dystrophic epidermolysis bullosa.
Goto M; Sawamura D; Ito K; Abe M; Nishie W; Sakai K; Shibaki A; Akiyama M; Shimizu H
J Invest Dermatol; 2006 Apr; 126(4):766-72. PubMed ID: 16439972
[TBL] [Abstract][Full Text] [Related]
17. The design and optimization of RNA trans-splicing molecules for skin cancer therapy.
Gruber C; Koller U; Murauer EM; Hainzl S; Hüttner C; Kocher T; South AP; Hintner H; Bauer JW
Mol Oncol; 2013 Dec; 7(6):1056-68. PubMed ID: 23998959
[TBL] [Abstract][Full Text] [Related]
18. Restoration of type VII collagen expression and function in dystrophic epidermolysis bullosa.
Chen M; Kasahara N; Keene DR; Chan L; Hoeffler WK; Finlay D; Barcova M; Cannon PM; Mazurek C; Woodley DT
Nat Genet; 2002 Dec; 32(4):670-5. PubMed ID: 12426566
[TBL] [Abstract][Full Text] [Related]
19. Phase I/II ex vivo gene therapy clinical trial for recessive dystrophic epidermolysis bullosa using skin equivalent grafts genetically corrected with a COL7A1-encoding SIN retroviral vector (GENEGRAFT).
Hum Gene Ther Clin Dev; 2014 Jun; 25(2):65-6. PubMed ID: 24933565
[No Abstract] [Full Text] [Related]
20. Long-term follow-up of patients with recessive dystrophic epidermolysis bullosa in the Netherlands: expansion of the mutation database and unusual phenotype-genotype correlations.
van den Akker PC; van Essen AJ; Kraak MM; Meijer R; Nijenhuis M; Meijer G; Hofstra RM; Pas HH; Scheffer H; Jonkman MF
J Dermatol Sci; 2009 Oct; 56(1):9-18. PubMed ID: 19665875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
